acid reflux while on glp 1 Heartburn and GLP-1 Treatments Can I Safely Use Semaglutide

So lets take a look at the logic behind microdosing GLP-1 and GIP meds (the combination fo

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are gaining increasing attention as first-line agents for the treatment of diabetes and obesity, and with their potential to improve the muscle mass and function, they provide new ideas for the treatment of sarcopenia

Does Mounjaro cause diverticulitis

When varying the grace period between 60 days and 365 days, treatment discontinuation rates at 3 years ranged from 23.3% to 43.6% among GLP-1 receptor agonist users and from 28.8% to 50.6% among SGLT2 inhibitor users

Major Update in Obesity Care: New ADA Guidelines (2026) The American Diabetes Association has released new, evidence-based guidance on the pharmacologic treatment of obesity and this is not a minor update